poisar

Stocks · News reference

Coca-Cola Deals Pepsi a Stinging Blow, Snatches KFC After Nearly 40 Years

BenzingaNeeraj Jain

Ending a 40-year deal, KFC replaces Pepsi with Coca-Cola at 3,600 U.S. locations as part of its "Kentucky Fried Comeback."

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncOut Of Home Advertising Association Of America (Oaaa)

    OAAA Announces Winners of the 84th Annual OBIE Awards

    The OAAA announced the 84th Annual OBIE Awards winners, recognizing excellence in out-of-home advertising. Paramount was inducted into the 2026 OBIE Hall of Fame for its creative excellence and commitment to OOH advertising. Random House Publishing Group and Known won the Platinum OBIE Award for 'Steph Curry Shoots the Moon,' while other major brands including Netflix, OpenAI, United Airlines, and Coca-Cola received recognition across various categories.

  2. Zacks Investment ResearchZacks Investment Research

    The Zacks Analyst Blog Highlights Chipotle Mexican Grill, Dutch Bros and McDonald's

    Chipotle is positioning Europe as a key growth avenue, with improving restaurant economics and strong comparable sales in Q2 2026. The company plans to expand its European development pipeline while maintaining direct ownership and operations. Chipotle's 2027 earnings are expected to grow 19.2% year-over-year, earning a Zacks Rank #2 (Buy) rating.

  3. Zacks Investment ResearchNa

    Bear of the Day: Krispy Kreme (DNUT)

    Krispy Kreme has been downgraded to a Zacks Rank #5 (Strong Sell) due to multiple structural challenges. The surge in GLP-1 weight-loss drug adoption is significantly reducing demand for sugary baked goods, with studies showing sweet bakery purchases plunge nearly 10% after patients start these medications. Additionally, the company faces negative revenue growth projections through 2027, chronic stock underperformance (down 78.8% over 5 years), a deteriorating balance sheet with debt-to-equity ratios nearly tripling since 2022, and a stock price below $3 that deters institutional investors.